In wake of a spurt in monkeypox cases in some foreign countries, a health expert on Saturday insisted on observing the evolution of the disease while also advising not to panic.
The Centre on Friday issued an alert to the National Centre for Disease Control (NCDC) and the Indian Council of Medical Research (ICMR) and asked them to keep a close watch on the situation evolving in relation to the monkeypox cases abroad.
"Everything should be taken seriously. And we should keep a guard but at the same time, there is no need to get panic. We need to study how it is evolving, and how many people are getting affected. Fortunately, it is not that severe as smallpox," said Dr Ishwar Gilada, infectious diseases expert and consultant for HIV/STDs, while speaking to ANI.
"Currently we do not know how many people are really dying, whether they've received any treatment or not. We do not know the treatment and maybe the smallpox vaccine can be used as a treatment. Maybe, it can be used as a treatment, but we do not know that yet," he added.
Elaborating on the monkeypox spread in 11 countries, according to the WHO, Dr Gilada said that such viruses spread in animals and later take a jump to the humans.
"Monkeypox is Zoonotic, such viruses spread in animals, but take a jump to humans. About COVID-19 we do not know whether it's Zoonotic or not. But, for example, HIV is zoonotic, initially, it came as a monkey virus called simian immunodeficiency virus, SIV, and then it became HIV," he said.
"So, this is monkey virus, or monkeypox, which was first noticed in monkeys only, it was around 1958 and it was in the rain forest area of Central Africa. But thereafter, sometime, it may have spread to the human beings, but the first cases were diagnosed only in the 1980s," Dr Gilada added.
Explaining the type of virus and the availability of their treatment, the expert said, "basically, what we are currently worried is a lot of new infections will be viral infections. Usually, there are four types of infections bacterial, fungal, parasitic, and virals."
"We have very effective antibiotics to take care of the bacteria, very effective antifungus to protect from fungus and very potent anti-parasitic. Now new infections, what we are seeing in the last 40 years are all viral because there are no potent antivirals and viruses are very much different like RNA virus, DNA virus, they are versatile, they change their shape, they have different clades they have different variants, sub-variants, so it becomes very difficult to find antiviral," Dr Gilada said.
Meanwhile, the WHO has confirmed 80 cases of monkeypox in 11 countries and said they are working to better understand the extent and cause of the outbreak.
In a statement issued on Friday, the WHO said the virus is endemic in some animal populations in a number of countries, leading to occasional outbreaks among local people and travellers.
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe.
According to WHO, Monkeypox typically presents clinically with fever, rash and swollen lymph nodes and may lead to a range of medical complications. Monkeypox is usually a self-limited disease with symptoms lasting from 2 to 4 weeks.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)